Reduction in the levels of ESR1 via the DSCAM-AS1/miR-130a axis also correlates with a decrease in the cancerous properties of cells, impeding breast cancer cell invasion and migration, similar to progesterone treatment [11, 26]. Here, ESR1 is linked to breast carcinoma.